The study found that TARGET had fewer dropouts than PE (i.e., 29 percent vs. 64 percent). At post test, improvements were found for both interventions in increased emotion regulation and hope, and reduced PTSD symptoms, hostility, experiential avoidance, and mental health problems. At a 4 month follow up, comparable proportions (approximately 40 percent) of recipients in each therapy maintained clinically significant gains. Self rated expectancy of therapeutic outcome and working alliance was comparable for both PE and TARGET early in therapy, at mid treatment, and at the end of treatment. Although preliminary, these results suggest that TARGET may be a viable therapeutic option for male military veterans with PTSD and anger problems. (publisher abstract modified)
Downloads
Similar Publications
- The cross-reactivity of cannabinoid analogs (delta-8-THC, delta-10-THC and CBD), their metabolites and chiral carboxy HHC metabolites in urine of six commercially available homogeneous immunoassays
- Broadband Capacitively Fed Tapered Type PIFA With Modified Ground Plane
- DNA-Based Identification of Forensically Important Lucilia (Diptera: Calliphoridae) in the Continental United States